SEARCH

SEARCH BY CITATION

References

  • 1
    Finno CJ , Valberg SJ , Wünschmann A , Murphy MJ . Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998–2005). J Am Vet Med Assoc 2006;229:11341141.
  • 2
    Bowen JN , Craig JF . Myoglobinuria in horses. Vet Rec 1942;35:354.
  • 3
    Votion DM , Serteyn D . Equine atypical myopathy: A review. Vet J 2008;178:185190.
  • 4
    Brandt K , Hinrichs U , Glitz F , et al. Atypische Myoglobinurie der Weidepferde. Pferdeheilkunde 1997;13:2734.
  • 5
    Votion DM , Linden A , Saegerman C , et al. History and clinical features of atypical myopathy in horses in Belgium (2000–2005). J Vet Intern Med 2007;21:13801391.
  • 6
    Van Galen G , Amory H , Busschers E , et al. European outbreak of atypical myopathy in the autumn 2009. J Vet Emerg Crit Care 2010;20:528532.
  • 7
    Westermann CM , Dorland L , Votion DM , et al. Acquired multiple acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul Disord 2008;18:355364.
  • 8
    Frerman FE , Goodman SI . Defects of electron transfer flavoprotein and electron transfer flavoprotein ubiquinone oxidoreductase: Glutaric acidemia type II. In: Scriver CR , Beaudet AL , Sly WS , Valle D , eds. The Metabolic and Molecular Bases of Inherited Diseases. New York: McGraw-Hill; 2001:23572365.
  • 9
    Das AM , Steuerwald U , Illsinger S . Inborn errors of energy metabolism associated with myopathies. J Biomed Biotechnol 2010;2010:340849.
  • 10
    Gregersen N . The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymatic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Scand J Clin Lab Invest Suppl 1985;174:160.
  • 11
    Duran M , Bruinvis L , Ketting D , Dorland L . Diagnosis of mitochondrial fatty acid oxidation defects. Paediatr Paedol 1993;28:1925.
  • 12
    Costa CG , Guérand WS , Struys EA , et al. Quantitative analysis of urinary acylglycines for the diagnosis of β-oxidation defects using GC-NCI-MS. J Pharm Biomed Anal 2000;21:12151224.
  • 13
    Vreken P , Van Lint AEM , Bootsma AH , et al. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidemias and fatty acid oxidation defects. J Inher Metab Dis 1999;22:302306.
  • 14
    Kobayashi H , Hasegawa Y , Endo M , et al. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. J Chromatogr B 2007;855:8087.
  • 15
    Schultz NE , Valberg SJ , Lucio M . Assessment of intramyofiber lipid content in horses. J Vet Intern Med 2010;24:780781.
  • 16
    Wen B , Dai T , Li W , et al. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations. J Neurol Neurosurg Psychiatry 2010;81:231236.
  • 17
    Kerner J , Hoppel C . Fatty acid import into mitochondria. Biochim Biophys Acta 2000;1486:117.
  • 18
    Sauer SW , Okun JG , Hoffann GF , et al. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 2008;1777:12761282.
  • 19
    Campos Y , Huertas R , Bautista J , et al. Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy. Muscle Nerve 1993a;16:778781.
  • 20
    Campos Y , Huertas R , Lorenzo G , et al. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 1993b;16:150153.
  • 21
    Westermann CM , Dorland L , van Diggelen OP , et al. Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. Mol Genet Metab 2011;104:273278.
  • 22
    Cassart D , Baise E , Cherel Y , et al. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J 2007;39:2632.
  • 23
    Pagan J , Essén-Gustavsson B , Lindholm A , Thornton J . The effect of dietary energy source on exercise performance in Standardbred horses. In: Gillespie JR , Robinson NE , eds. Equine Exercise Physiology 2: Proceedings of the Second International Conference on Equine Exercise Physiology. Davis, CA: ICEEP Pub; 1987:686700.
  • 24
    Taylor R , Magnusson I , Rothman DL , et al. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 1996;97:126132.
  • 25
    Van Galen G , Serteyn D , Amory H , Votion DM . Atypical myopathy: New insights into the pathophysiology, prevention and management of the condition. Equine Vet Educ 2008;20:234238.
  • 26
    Spiekerkoetter U , Bastin J , Gillingham M . Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis 2010;33:555561.
  • 27
    Liang WC , Nishino I . Lipid storage myopathy. Curr Neurol Neurosci Rep 2011;11:97103.
  • 28
    Corr PB , Creer MH , Yamada KA , et al. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927936.
  • 29
    Rinaldo P , Schmidt-Sommerfeld E , Posca AP , et al. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1993;122:580584.
  • 30
    Moyano D , Vilaseca MA , Pineda M , et al. Tocopherol in inborn errors of intermediary metabolism. Clin Chim Acta 1997;263:147155.
  • 31
    Zolkipli Z , Pedersen CB , Lamhonwah AM , et al. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: Response to antioxidants. PLoS ONE 2011;6:e17534.
  • 32
    Olsen RKJ , Andresen BS , Christensen E , et al. Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency. Hum Mutat 2003;22:1223.
  • 33
    Spaan AN , Ijlst L , van Roermund CW , et al. Identification of the human mitochondrial FAD transporter and its potential role in multiple acyl-CoA dehydrogenase deficiency. Mol Genet Metab 2005;86:441447.
  • 34
    Unger-Torroledo L , Straub R , Lehmann AD , et al. Lethal toxin of Clostridium sordellii is associated with fatal equine atypical myopathy. Vet Microbiol 2010;144:487492.
  • 35
    Van der Kolk JH , Wijnberg ID , Westermann CM , et al. Equine acquired multiple acyl-CoA dehydrogenase deficiency (MADD) in 14 horses associated with ingestion of maple leaves (Acer pseudoplatanus) covered with European tar spot (Rhytisma acerinum). Mol Genet Metab 2010;101:289291.